Consumer Genomics Market Share, Size, Trends, Industry Analysis Report, By Application (Genetic Relatedness, Ancestry, Diagnostics, Sports Nutrition & Health), By Region, And Segment Forecasts, 2024 - 2032
The global consumer genomics market size is expected to reach USD 11.37 billion by 2032, according to a new study by Polaris Market Research. The report “Consumer Genomics Market Share, Size, Trends, Industry Analysis Report, By Application (Genetic Relatedness, Ancestry, Diagnostics, Sports Nutrition & Health), By Region, And Segment Forecasts, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increasing interest from both consumers and physicians in DTC kits, coupled with the surge in the sales of the DNA test kits, and the growing popularity of personalized genomics, are anticipated to fuel market expansion over the forecast period. Common tests often utilize a small number of genetic changes to predict specific health characteristics, unveil common traits, and offer ancestry insights.
As the range of health information these tests can uncover continues to expand, more companies are entering the market, offering genetic testing directly to consumers. This trend is driven by the growing demand for accessible and personalized genetic information among individuals seeking insights into their health, traits, & ancestry.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/consumer-genomics-market/request-for-sample
The increased interest from both consumers and physicians in DTC kits, advancements in technology, a rise in the applications of consumer genomics, supportive governmental policies, and the growing trend of personalized genomics collectively contribute to the expansion of the market. Notably, DTC tests gained prevalence in 2022 as they became more accessible, allowing individuals to purchase these tests without the need for a doctor's prescription. This shift in accessibility has democratized access to genetic information, enabling more people to explore and understand their genetic make-up without the traditional barriers of medical intermediaries.
The COVID-19 pandemic has significantly increased public awareness and concerns about health, leading to a heightened interest in innovative approaches such as consumer genomics. This surge in awareness is expected to contribute to the sustained growth of the consumer genomics market. One key factor driving this growth is the rising focus on DNA-based research & development (R&D) efforts, particularly in the field of bioinformatics. Researchers are leveraging genetic information to develop diagnostic tools and more efficient therapies, with a specific focus on addressing the challenges posed by the COVID-19 virus.
Consumer Genomics Market Report Highlights
Genetic relatedness segment held the largest share, due to its involvement in the parental testing, family analysis, and family borne mutations
Dissolving microneedle segment will grow at the fastest rate, as it requires minimum steps to operate and do not need to be removed even after being operated
Asia Pacific projected to experience growth over the study period, owing to rise in awareness of DTC genetics, and availability of funding in several research works
North America held the largest revenue share, owing to presence of innovative companies, huge patient population, and positive scenario for start-up funding
The global players include 23andMe, AgeCurve, Amgen, Ancestry, Biomeb, Color Health, Diagnomics, Futura Genetics, MyHeritage, Myriad Genetics, Pathway Genomics, Positive Biosciences, Gene by Gene, Helix OpCo, and Illumina.
Polaris Market Research has segmented the consumer genomics market report based on application, and region:
Consumer Genomics, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Genetic Relatedness
Ancestry
Lifestyle, Wellness, & Nutrition
Diagnostics
Sports Nutrition & Health
Reproductive Health
Personalized Medicine & Pharmacogenetic testing
Others
Consumer Genomics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
Latin America
Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa